11:37 AM EST, 01/15/2025 (MT Newswires) -- (Updates shares.)

HYTN Innovations ( HYTNF ) , which produces pharmaceutical-grade cannabis, late Tuesday said it received new permits allowing it to fulfill international orders of over 400 kilograms of Good Manufacturing Practice (GMP) cannabis products.

The import permits were issued by the U.K.'s Home Office and corresponding export permits were from Health Canada.

HYTN is seeking to transition from a cannabis producer primarily serving the Canadian recreational market to a global manufacturer of non-sterile pharmaceuticals. The company previously said it is dedicated to meeting stringent GMP standards and addressing the growing demand from regulated markets globally.

HYTN's shares were last seen up $0.025 to $0.46 on the Canadian Securities Exchange.

Price: 0.45, Change: +0.02, Percent Change: +3.49